dc.contributor.author |
Clarens, María Florencia |
|
dc.contributor.author |
Chrem Méndez, Patricio Alexis |
|
dc.contributor.author |
Tapajoz, Fernanda |
|
dc.contributor.author |
Martinez, Carlos |
|
dc.contributor.author |
Helou, María Belén |
|
dc.contributor.author |
Surace, Ezequiel Ignacio |
|
dc.contributor.author |
Crivelli, Lucía |
|
dc.contributor.author |
Romero, Daniela |
|
dc.contributor.author |
Vigo, Gabriela |
|
dc.contributor.author |
Allegri, Ricardo Francisco |
|
dc.date.accessioned |
2024-08-12T17:49:11Z |
|
dc.date.available |
2024-08-12T17:49:11Z |
|
dc.date.issued |
2023-12-25 |
|
dc.identifier.citation |
Clarens MF, Mendez PC, Tapajoz F, Martinez C, Helou B, Surace E, Crivelli L, Romero D, Vigo G, Allegri RF. Clinical Manifestations. Alzheimers Dement. 2023 Dec;19 Suppl 18:e078170. doi: 10.1002/alz.078170 |
es_ES |
dc.identifier.uri |
https://doi.org/10.1002/alz.078170 |
|
dc.identifier.uri |
https://repositorio.fleni.org.ar/xmlui/handle/123456789/1190 |
|
dc.description.abstract |
Background: In recent years, there has been an increase in the number of case reports of families with autosomal dominant Alzheimer's disease (ADAD) in Latin America (LA). Nevertheless, little is known about the clinical phenotypes and demographic characteristics of mutations in each country. Past literature has proved that variants in LA have different and unique characteristics than those reported in Asia, North America, and Europe. Clinical heterogeneity in ADAD supports the need to study clinical phenotypes, especially in preclinical stages, to develop cognitive and clinical markers of the disease. We aimed to describe clinical and cognitive characteristics at baseline assessment of an Argentina PSEN1 p.M146L family enrolled at DIAN.
Method: Fifteen Dian Participants living in Buenos Aires and its suburbs and in Taco Pozo, a rural and isolated community from the Province of Salta, positive for the PSEN1 p.M146L mutation, were recruited. DNA was obtained from peripheral blood leukocytes according to standard protocols. In addition, exon 5 of the PSEN1 gene was PCR-amplified, and Sanger sequencing was performed. NACC Uniform Data Set clinical assessment, including the 2.0 UDS Neuropsychological Battery, was administered. Two groups were used to compare cognitive data: Patients with CDR:0 (n:10) and patients with CDR>0 (n:5).
Result: The mean age at symptom onset reported in this cohort was 42,90 (SD: 4,62). Significant differences were found in several cognitive measures: Logical Memory Immediate, TMT B and Digit Backward (<0,001); MMSE, Category Fluency Animals, TMT A and Digit Symbol(<0,05). In neurological signs, paraplegia was reported in one of the patients.
Conclusion: As expected, differences in neuropsychological tests showed a prevalence of memory deficits, however, dysexecutive symptoms were also present for this mutation. Paraplegia in PSEN1 p.M146L has not been reported in the literature so far. Ongoing longitudinal work will be important in tracking changes in this cohort. Other characteristics, proper of underrepresented groups, such as socioeconomic status, education, race, and ethnicity, deserve appropriate follow-up. Future studies are planned, comparing urban and rural populations in this cohort with the same mutation. |
es_ES |
dc.language.iso |
eng |
es_ES |
dc.publisher |
Wiley |
es_ES |
dc.subject |
Alzheimer Disease |
es_ES |
dc.subject |
Enfermedad de Alzheimer |
es_ES |
dc.subject |
Argentina |
es_ES |
dc.subject |
Mutation |
es_ES |
dc.subject |
Mutación |
es_ES |
dc.subject |
Neuropsychological Tests |
es_ES |
dc.subject |
Pruebas Neuropsicológicas |
es_ES |
dc.subject |
Phenotype |
es_ES |
dc.subject |
Fenotipo |
es_ES |
dc.subject |
Presenilin-1 |
es_ES |
dc.subject |
Presenilina-1 |
es_ES |
dc.title |
Clinical Manifestations |
es_ES |
dc.type |
info:eu-repo/semantics/article |
es_ES |
dcterms.rights |
info:eu-repo/semantics/openAccess |
|
dcterms.type |
info:eu-repo/semantics/publishedVersion |
|
dc.description.fil |
Fil: Clarens, María Florencia. Fleni. Departamento de Neurología. Servicio de Neurología Cognitiva, Neuropsicología y Neuropsiquiatría; Argentina. |
|
dc.description.fil |
Fil: Chrem Méndez, Patricio Alexis. Fleni. Departamento de Neurología. Servicio de Neurología Cognitiva, Neuropsicología y Neuropsiquiatría. Centro de Memoria y Envejecimiento; Argentina. |
|
dc.description.fil |
Fil: Tapajoz, Fernanda. Fleni. Departamento de Neurología. Servicio de Neurología Cognitiva, Neuropsicología y Neuropsiquiatría; Argentina. |
|
dc.description.fil |
Fil: Martinez, Carlos. Fleni. Departamento de Neurología. Servicio de Neurología Cognitiva, Neuropsicología y Neuropsiquiatría; Argentina. |
|
dc.description.fil |
Fil: Helou, Belén. Fleni. Departamento de Neurología. Servicio de Neurología Cognitiva, Neuropsicología y Neuropsiquiatría; Argentina. |
|
dc.description.fil |
Fil: Surace, Ezequiel Ignacio. Fleni. Departamento de Neuropatología y Biología Molecular; Argentina. |
|
dc.description.fil |
Fil: Crivelli, Lucía. Fleni. Departamento de Neurología. Servicio de Neurología Cognitiva, Neuropsicología y Neuropsiquiatría; Argentina. |
|
dc.description.fil |
Fil: Allegri, Ricardo Francisco. Fleni. Departamento de Neurología. Servicio de Neurología Cognitiva, Neuropsicología y Neuropsiquiatría; Argentina. |
|
dc.relation.ispartofVOLUME |
19 |
|
dc.relation.ispartofNUMBER |
Suppl 18 |
|
dc.relation.ispartofCOUNTRY |
Estados Unidos |
|
dc.relation.ispartofCITY |
Hoboken |
|
dc.relation.ispartofTITLE |
Alzheimer's & dementia |
|
dc.relation.ispartofISSN |
1552-5279 |
|
dc.type.snrd |
info:ar-repo/semantics/artículo |
es_ES |